New Treatment for Seizures
What is FYCOMPA (perampanel)?
FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged 4 and older. It is also used with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older.
Watch an overview of Fycompa in LGS
– Presented by Dr. Michael Chez
Data from a recent study suggest that treatment with perampanel (Fycompa; Eisai) is safe and well-tolerated in patients with LGS. Findings were presented at the 2021 American Epilepsy Society (AES) Annual Meeting, December 3-7 in Chicago and virtually.
More information about medication access assistance to patients, caregivers, and their medical teams can be found at www.FYCOMPA.com.
The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options.